Saturday, October 26, 2019

Healthcare costs increasingly shifting to patients, study shows





13 September 2019

Out-of-pocket spending on health by households in Australia is rising faster than overall household spending on goods and services—and taking an increasingly bigger slice of the household budget, according to a research study published today in Australian Health Review, the journal of the Australian Healthcare and Hospitals Association (AHHA).
The study, by Sydney University researchers Professor Farhat Yusuf and Professor Stephen Leeder, uses consumer-reported data gathered by the Australian Bureau of Statistics Household Expenditure Survey.
Household out-of-pocket (OOP) spending on healthcare rose by more than 25% over a recent 6-year period while overall household spending on goods and services rose by 15%.
In 2015–16, the mean amount spent by households on healthcare out of their own pockets was $4,290, or 5.8% of total household expenditure.
The most expensive OOP item was private health insurance ($1,744), followed by non-PBS medicines ($585), specialists ($438) and dentists ($396). Spending on GPs was $96.
The biggest percentage rises in out-of-pocket healthcare costs between 2009–10 and 2015–16 were for health insurance (51% rise), co-payments to ‘other health professionals’ (42% rise), and co-payments to specialists (35% rise).
‘Out-of-pocket expenses on healthcare as a proportion of the total household budget has been rising in real terms since 1984’, said AHHA Chief Executive Alison Verhoeven.
‘This study notes that the progressive movement of healthcare costs “from public to person” has occurred “without policy debate, slowly and steadily, with small steps such as freezing Medicare rebates”.
‘Other more recent data suggest that OOP costs have continued rising right to the present day.’ The situation was brought to a head earlier this year with media reports of huge five-figure co-payments for some types of medical and surgical care, particularly cancer care, with dire financial consequences for individuals as a result.
‘Yet, there is no evidence that higher OOP costs are related to better quality of care or increased access to care.
‘This creeping burden on individuals challenges our notions of universal healthcare, a fair go, and care based on medical need rather than the depth of your pockets’, Ms Verhoeven said.
The study found that OOP costs were highest among affluent households, especially those holding private health insurance.
Correspondingly, OOP costs were lowest in low-income households, but no data were available on to what extent care was skipped because of the cost. Other studies show, however, that OOP costs weigh most heavily on individuals with low incomes and multiple health problems.
‘This individual upward drift in out-of-pocket health expenses deserves very serious policy attention before our nation’s health starts to drift downwards’, Ms Verhoeven said.
Recent estimates of out-of-pocket expenditure on health care in Australia is available at http://www.publish.csiro.au/ah/Fulltext/AH18191. This release is also available online.

The Australian Healthcare and Hospitals Association is the national peak body for public and not-for-profit hospitals, Primary Health Networks, and community and primary healthcare services.

Tuesday, October 22, 2019

A child shall lead them



Published in Australian Medicine 21 October 2019 https://bit.ly/2NhDL7B

Tuesday, September 17, 2019

Tuesday, August 27, 2019

Tuesday, June 25, 2019

I'm calling for the PM to lead from the front on prevention


With a new government in Canberra and good prospects of stability for the next three years, it is the perfect time to consider what could be done to develop and advance an agenda for prevention.

The Public Health Prevention Conference held in Melbourne earlier this month canvassed a host of possibilities.
Prevention is rarely achieved quickly, and a three-year time period allows for plans to be developed thoughtfully, coalitions built, and resources allocated carefully and without haste.
There are two principal channels for prevention that could be used to good effect.

First, we should accept that prevention can be highly effective when applied in hospital, the GP surgery and the home.
This variety of prevention concentrates on the individual; ensuring that they are immunised and encouraged (where possible) to live in a way that reduces their risk of chronic illness by not smoking, having their blood pressure checked regularly and taking part in screening programs.
As a nation, we are doing reasonably well with this kind of prevention, something Minister for Health Greg Hunt concentrated on in his video speech to the Melbourne conference.
He challenged the audience to come forward with “your advice, your comments, frank and fearless as always”.
He concentrated on immunisation and cancer prevention such as cervical and bowel cancer programs.
But treatments can be preventive, too. A senior cardiologist friend of mine who works in New York said to me recently: “I used to see lots of patients turning up in the ED with malignant hypertension. These days I see virtually none.”
He credits this to the widespread use of antihypertensives.
He accepts that these drugs are used irregularly by many patients, but the cumulative effect of their widespread prescription, he believes, has been to reduce the incidence of malignant hypertension. Maybe he’s right.
The effective treatment for HIV prevents transmission from affected people to their negative partners is another good example.
Certainly, there are many opportunities for prevention in clinical medicine, but time and financial pressures make it easy for the busy practitioner to pass these over.
In view of this, it would be beneficial on a national level if government and its departments worked with specialist colleges, pharmaceutical companies and patients to set an agenda to make the most of these ‘golden moments’.
Another kind of prevention
The second variety of prevention is much more difficult and lies largely outside the purview of medicine: it received extensive coverage at the Melbourne conference.
Six years ago, I attended a one-day meeting at Parliament House convened by Senator Guy Barnett, who was concerned about the rising rate of diabetes.
He gathered physicians, diabetes educators, representatives of the food and advertising industries, patients, and several politicians.
I chaired a working group of industry representatives. We had a congenial conversation and agreed that we would need to work together to create a healthier food environment.
Towards the end of the day, one member interrupted. “Professor,” he said. “You’ve got the wrong people in the room today. You need the CEOs. We can’t make decisions to change the composition of our products. They can. And, by the way, you’re the wrong person, too.”
I accepted his criticism: it made sense. But who would he suggest take my place?
“The Prime Minister,” he replied. “Only he would have the authority to mix it with the CEOs.”
Perhaps this is logistically impossible, but only something like it will enable the beginning of an agenda for prevention in our communities.
Agendas that are set by top-level people, be they politicians or business managers, have a better chance of changing things than ones that come from people lower down the organisation — like my friends at the diabetes workshop.
Such agendas do not require the ‘top dogs’ to do all the barking but the top men and women need to endorse and value the development of a strategy.
This is not for a moment to suggest that grassroots-level efforts are out of place. Far from it. They can serve to sensitise the people at the top to the need for change and suggest ways forward.
But we do need top-level support to succeed. It will take time to transact, but like concerns with the climate, the sooner we start the better.
Published in the Medical Observer 24 June 2019 http://bit.ly/2WZEzAM


Monday, June 24, 2019